August 2015 - ISSUE 16  

Updates to Mandatory California Law

California Compliance Dates for Small Bore Connectors have been extended

On August 13 2015 California Governor Jerry Brown signed the California Senate Bill AB 444  delaying the California mandate which prohibits use of enteral, epidural and IV connectors for purposes other than the type which it was intended.  The new deadlines outlined in AB444 are as follows:
  • July 1, 2016 for enteral connector design
  • January 1, 2017 for epidural (neuraxial) connectors

To ensure a smooth and successful transition to ENFit™  connectors suppliers will start to introduce ENFit tip syringes and feeding tubes Q1 of 2016.

View the revised California law

  Did you know?  

Timelines have been updated

Timelines for ENFit connectors have an introduction date of Q1 2016 for ENFit tip syringes and ENFit feeding tubes.  Brochures have been updated to reflect the most recent timeline.

Find a brochure with the latest timeline 

  Do you have?  

Enteral Specific FAQ's

Enteral connectors will be the first of the 80369 series of small bore connector changes.  Download our FAQ set focusing on the changes in enteral connectors and the new ENFit system.

Download the Enteral FAQ

  Have you met?  

Gina Hogan, RN
Clinical Advisory Services Director, MedAssets

Gina has worked in the GPO setting since 2009 directing the integration of the clinical contract portfolio in conjunction with the client's value analysis committee process.  Currently, as a Director of Clinical Advisory Services at MedAssets, Gina acts as the liaison between her customers and the GPO to establish positive, collaborative integration during clinical, business and technical discussions.  She currently facilitates discipline specific, clinical advisory committees where decisions for improved product and service utilization are client led.  Gina supports lowering hospital costs, reducing excess SKU's and initiating clinical best practices.


"Strong relationship building skills are key in an environment where diverse groups must gain consensus across numerous hospitals or systems.  It is exciting to know that we are a part of this ground breaking international effort, under ISO standards, to establish products which prevent and manage the risk of tragic adverse events involving tubing and catheter misconnections" -Gina Hogan, RN

  Have you told?  

The transition to the new ENFit connectors will take a coordinated effot that includes your colleagues from purchasing, materials management, logistics, inventory management, demand planning, forecasting, and more.

Forward this email to your colleagues


Where to find us

September 5-8

European Society for Clinical Nutrition and Metabolism (ESPEN) 2015 Congress; Lisbon Portugal

October 18-21

American Society for Healthcare Risk Management (ASHRM) 2015 Conference; Indianapolis, Indiana

December 6-10

American Society of Health-System Pharmacists 50th Midyear Clinical Meeting; New Orleans, Louisana


The Stay Connected initiative is organized by the Global Enteral Device Supplier Association (GEDSA) in partnership with leading regulators, associations and other supporting organizations.


If this email was forwarded to you and you would like to sign up to Stay Connected, click here.

© 2015 GEDSA, all rights reserved

692 N. High St. Suite 207
Columbus, OH 43215 USA

Unsubscribe | Privacy

GEDSA is a 501(c)(6) federal tax exempt Non-Profit Trade Association incorporated in the State of Ohio, USA. GEDSA’s mission is to promote initiatives surrounding safe and optimal delivery of enteral feeding and connectivity. It is GEDSA’s policy and the responsibility of every GEDSA member to comply in all respects with federal, state and international antitrust laws. Any discussion is strictly prohibited for the purpose of raising, lowering, or stabilizing prices; regulating production; allocating markets; encouraging boycotts; fostering unfair trade practices; or assisting monopolization at any GEDSA function. Any questions regarding the meaning or applicability of this policy, as well as any concerns regarding activities or discussions at GEDSA functions, should be promptly brought to the attention of GEDSA’s executive director, officers, and/or legal counsel.

All material provided in this email is intended for informational purposes only and should not be used to replace regulatory or company-specific documents, nor should it replace the advice of a qualified professional. This information is based on the draft ISO 80369 standard; does not imply or suggest any regulatory clearance of any specific product and may not be predictive of clinical outcomes. Images provided do not imply endorsement of any specific product. All products and product designs are the responsibility of each specific legal manufacturer, distributor or supplier. Products with these design features may be pending regulatory clearance or may not be available in a specific geography. Consult your supplier representative for product-specific availability, indications, contraindications, precautions, and warnings.


This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
GEDSA · 692 N. High St. Suite 304 · Columbus, OH 43215 · USA